Literature DB >> 24179622

A correction of misinformation regarding Herbalife.

Kristy Appelhans1, Raushanah Najeeullah, Vasilios Frankos.   

Abstract

The authors of the subject article by Senadhi et al have misrepresented the safety and regulatory status of Herbalife's products. While we are very concerned with the unwarranted and unfavorable publicity that the inaccuracies listed could generate for Herbalife, we would welcome any inquiries that these authors may have to better clarify our commitment to the safety and quality of our products as has been demonstrated in part by our ability to establish positive relationships with regulatory authorities worldwide through continued cooperation and compliance. This letter clarifies the misinformation presented about Herbalife in the subject article.

Keywords:  Dietary supplements; Drug-induced liver injury; Hepatitis; Herbal; Herbalife

Year:  2013        PMID: 24179622      PMCID: PMC3812465          DOI: 10.4254/wjh.v5.i10.601

Source DB:  PubMed          Journal:  World J Hepatol


  3 in total

1.  Revisiting acute liver injury associated with herbalife products.

Authors:  Kristy Appelhans; Casey Smith; Ezra Bejar; Y Steve Henig
Journal:  World J Hepatol       Date:  2011-10-27

2.  Acute liver injury induced by weight-loss herbal supplements.

Authors:  Gary C Chen; Vivek S Ramanathan; David Law; Pauline Funchain; George C Chen; Samuel French; Boris Shlopov; Viktor Eysselein; David Chung; Sonya Reicher; Binh V Pham
Journal:  World J Hepatol       Date:  2010-11-27

3.  A rare cause of drug-induced hepatitis in an immunocompromised patient and the role of glutathione.

Authors:  Viplove Senadhi; Deepika Arora; Manish Arora; Franklin Marsh
Journal:  World J Hepatol       Date:  2012-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.